Incox

Oral antiangiogenic, powerful and selective inhibitor of tyrosine kinase of endothelial growth factor receptors (VEGFR). Indicated to treat adult patients with advanced renal cells cancer.

Therapeutic Area
Antineoplastic + Inhibitor of Protein kinase of Vegfr-1 Vegfr-2 and Vegfr-3.

Active Ingredient
Axitinib

Line
Oncology

Pharmaceutical Forms
1 mg x 56 coated tablets
5 mg x 56 coated tablets

Download Leaflet Descargar